Description
Inclusion Criteria:
- * At least 50 years of age.
- * Able to understand written and spoken English.
- * Able to understand and willing to sign an IRB-approved written informed consent document (or that of a legally authorized representative, if applicable for the trauma cohort)
Exclusion Criteria:
- * Inability or unwillingness to complete health questionnaire.
- * History of a recent (\<30 days) acute viral illness.
- * Current cancer diagnosis and currently receiving chemotherapy or undergoing radiation therapy. A prior history of cancer is allowed if the participant completed therapy \> 1 year prior to enrollment; participants with a prior diagnosis of cancer will be asked to sign a release of information for the research team to obtain records regarding their prior cancer treatment.
- * Current use of drugs that cause DNA damage (e.g. Cytoxan, azathioprine, etc.) for the treatment of a non-malignant disease.
- * Vulnerable populations (e.g. prisoners).
- * Known infection with Hepatitis B or C, HTLV, or HIV.
- * Additional exclusion for optional bone marrow aspirate/biopsy substudy:
- * Use of medications for anticoagulation or "blood thinning" including warfarin, low molecular weight heparins (enoxaparin, daltaparin) or direct-acting oral anticoagulants (dabigatran, rivaroxaban, apixaban, edoxaban or betrixaban)
- * allergy to lidocaine or other local anesthetics.
Ages Eligible for Study:
50 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Yes